Journal of Liver Cancer

Case Reports

Hemangioma Diagnosed by Gadoxetate Disodium-Enhanced MRI in a Patient with Chronic Hepatitis C: Jin Won Mo, Soo Hyung Ryu, Dong Won Park, Won Jae Yoon, Jin Nam Kim, Jeong Seop Moon, Jae-Chan Shim; J Liver Cancer. 2015;15(1):36-40. Published online March 31, 2015; DOI: https://doi.org/10.17998/jlc.15.1.36

Abstract PDF: A hemangioma is the most common benign hepatic tumor. Many hepatic hemangioma tend to be found incidentally, but should be differentiated from malignant tumors, especially in patients with a high risk for malignancy. We presented a 52-year-old woman who diagnosed as hepatic hemangioma. The patient was a chronic alcohol abuser and diagnosed as a hepatic C virus carrier for the first time. Contrast enhanced abdominal computed tomography (CT) revealed a 4cm sized hepatic mass involving both segment 5 and 6. Abdominal CT finding suggested hepatic hemangioma, but could not rule out the malignancy. Because the patient had risk factors for hepatocellular carcinoma, abdominal ultrasonography (US) was performed for further evaluation. But abdominal US also showed atypical finding. For the confirmative diagnosis, dynamic magnetic resonance imaging using gadoxetate disodium (primovist®, Bayer HealthCare, Berlin, Germany) which is the innovative liver cell-specific contrast medium was done, and the patient was diagnosed as hepatic hemangioma.

A Case of Liver Hemangioma Mimicking Hepatocellular Carcinoma: Hang Ju Cho, Il Young Park, Young Sok Lee, Nam Ik Han, Yeon Su Lim, Jean A Kim; Journal of the Korean Liver Cancer Study Group. 2003;3(1):53-56. Published online July 31, 2003

Abstract PDF: Cavernous hemangioma is the most common begin hepatic tumor. But unfortunately, differentiation with hepatocellular carcinoma is quite difficult especially in patients with an underlying liver cirrhosis. A 49-year-old man with alcoholic liver cirrhosis was admitted for evaluation of a hepatic lesion found during a routine follow up. There was no abnormal findings in the physical examination. The HBs Ag, anit-HBs Ab, anti-HCV Ab were all negative, with an AFP level of 3.28 ng/mL. The dynamic CT scan revealed a 2 cm sized mass with a heterogenously enhancement on arterial phase at S6, which became isoattenuation on portal phase and delayed phase. Angiographic study showed a hypervascular mass with an arteriovenous shunt and in the lipiodol CT, a 2 cm sized mass with a lipiodol uptake was detected in the same area. Segmentectomy of S6 was performed under the impression of HCC. The cut surface of the mass had a sponge like feature, and was pathologically defined as cavernous hemangioma. From out experience, we recommentd careful assessment and differentiation of hemangioma and hepatocellular carcinoma to avoid misdiagnosis and MRI might be helpful in this case.

Search